ranQ
ranQ
ranQ
DirectoryIndustriesPlacesKnowledgeComparisonsSoon
Sign inCheck visibility
ranQHSG Startup LabelRecognised by the
HSG Startup Label

The leading AI company directory, built to boost AI visibility.

DEENFRIT
Product
  • Pricing
  • Directory
  • Industries
  • Trust Score
Company
  • About
  • Partner program
  • Contact
  • Legal
© 2026 cohaga AG · All Rights Reserved · St. Gallen, Switzerland · Imprint745,887 companies indexed · Last updated: today
DirectoryIndustryPharmaceutical IndustrySchlierenNovaGo Therapeutics AG
NovaGo Therapeutics AG Logo
Verified· 3 sourcesTrust Score
Summary

About the company

The core activity of Neurimmune (or NovaGo) is the development of therapeutic antibodies for the treatment of neurodegenerative and other diseases, particularly Alzheimer's, Parkinson's, tauopathies, and amyotrophic lateral sclerosis. The company focuses on the discovery, development, and clinical testing of antibody-based medications.

AI-generated
Offering

Products & services

Industry:Pharmaceutical Industry
LeadhubOutbound Leads by COHAGA

Looking for direct email addresses and phone numbers?

Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.

Discover Leadhub
4.1/5

NovaGo Therapeutics AG

✓ Offered3
Development of human antibody therapeutics
Development of human antibody therapeutics to promote nerve growth and regeneration; focus on blocking Nogo-A and restoring functional connections after spinal cord injuries.
Development of therapy candidates for spinal cord injuries
Development of therapy candidates for the treatment of spinal cord injuries, including lead candidate NG004, as well as preclinical and early clinical development.
Research and development of anti-Nogo-A antibodies
Research and development of anti-Nogo-A antibodies in collaboration with Neurimmune AG, focusing on nerve regeneration and functional recovery in preclinical models.
Trust & reputation

ranQ Trust Score of NovaGo Therapeutics AG: 4.1 out of 5.0

Trust Score4.1/ 5.0

High

x

Data basis 58% · As of October 2026

Without public customer reviews the score stays capped.

NovaGo Therapeutics AG has no value in the Reputation area of the ranQ Trust Score because no data is available. The area carries 42% of the weighting and drops out of the calculation for this profile; it does not lower the score, only the reported data basis.
x
CriterionValueWeight
  • Review quality: No data point — the criterion is taken out of the weighting and does not lower the score.—24%
  • Review volume: No data point — the criterion is taken out of the weighting and does not lower the score.—10%
  • Review recency: No data point — the criterion is taken out of the weighting and does not lower the score.—8%
NovaGo Therapeutics AG scores 84.8 out of 100 points in the Substance area of the ranQ Trust Score. This area carries 28% of the weighting.
x
CriterionValueWeight
  • Establishment: Years since founding or brand launch, logarithmic. The maximum is reached at 15 years.89.612%
  • Company size: The headcount band, researched by ranQ or stated by the company. It is scored in steps rather than by head count, because the data only provides bands.70.07%
NovaGo Therapeutics AG scores 85.0 out of 100 points in the Identity area of the ranQ Trust Score. This area carries 22% of the weighting.
x
CriterionValueWeight
  • Verification: Official register entry (commercial register with UID or professional-body record, 55 points), confirmed domain (20 points) and confirmed ranQ profile (up to 25 points, depending on completeness).85.022%
NovaGo Therapeutics AG scores 49.3 out of 100 points in the Visibility area of the ranQ Trust Score. This area carries 8% of the weighting.
x
CriterionValueWeight
  • Website authority: Ahrefs' Domain Rating measures, on a scale of 0 to 100, how strongly a website is linked from other websites. For Swiss SMEs the range up to 40 is typical; the maximum is reached at 35.88.64%
  • Media authority: Quality and number of editorial mentions, weighted by the importance of the source, plus the recency of the latest high-quality mention.10.04%
Qualifications+0.00

NovaGo Therapeutics AG reaches a ranQ Trust Score of 4.1 out of 5.0 — rated «High». No public customer reviews are available for this provider; the rating is based on the remaining criteria. The data basis is 58%, so the score is backed by part of the criteria. As of October 2026.

The Trust Score cannot be bought and is calculated from publicly verifiable data.

Press

Media

September 23, 2020Media
Gründer übergeben an erfahrene CEOs
startupticker.ch

Knowledge

No knowledge articles yet

Once NovaGo Therapeutics AG has claimed this profile, we'll publish editorial articles and case studies here together.

Get started
Comparisons

NovaGo Therapeutics AG in comparison

Soon

Industry comparisons are coming soon

We're preparing industry comparisons that rank NovaGo Therapeutics AG by reviews, experience and specialisations.

Is this your company?

Claim the company profile of NovaGo Therapeutics AG to make its contact details visible. With a plan we additionally create and publish industry comparisons, articles and much more.

Secure profile

Location

Wagistrasse 27
8952 Schlieren
Opening hours
Mon
09:00 - 17:00
Tue
09:00 - 17:00
Wed
09:00 - 17:00
Thu
09:00 - 17:00
Fri
09:00 - 17:00
Sat
Closed
Sun
Closed

At a glance

Legal form
Corporation
UID
CHE-429.176.159
Founded
2015 · 11 years
Last commercial register change
August 13, 2026
Employees
11 to 20
Legal form: Graded by liability and disclosure. The weight is kept small: a sole proprietorship is not a dubious company, it is just liable differently.
100.0
6%
  • Branch offices: Branch offices linked in the commercial register. Having none is normal and costs no points.70.03%
    • Full methodology

    Similar companies

    AT
    Axanton Technology GmbH
    Schlieren
    MT
    Memo Therapeutics AG
    Schlieren
    MA
    Mabylon AG
    Schlieren
    MP
    Molecular Partners AG
    Schlieren
    AH
    AeoniQ Holding AG
    Schlieren
    PA
    Philochem AG
    Otelfingen
    EA
    EvlaBio AG
    Zurich
    RA
    REMUUN AG
    Zurich